Finance

Beta
Lists
JSPR:NASDAQ
Jasper Therapeutics Inc
0,46 USD
-6,24%
(-0,031) 1D
25-июн., 13:44:07 GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for JSPR...
Open
0,49 USD
High
0,52 USD
Low
0,46 USD
Mkt. cap
12,90 млн
Avg. vol.
582,15 миң
Volume
150,30 миң
52-wk high
7,19 USD
52-wk low
0,42 USD
EPS
-3,23 USD
Beta
3,00
Shares outstanding
28,01 млн
No. of employees
22
Open
0,49 USD
High
0,52 USD
Low
0,46 USD
Mkt. cap
12,90 млн
Avg. vol.
582,15 миң
Volume
150,30 миң
52-wk high
7,19 USD
52-wk low
0,42 USD
EPS
-3,23 USD
Beta
3,00
Shares outstanding
28,01 млн
No. of employees
22
News stories
From sources across the web
About Jasper Therapeutics Inc
CEO-
Employees22
Founded2018
HeadquartersРедвуд Сити, Калифорния, Америка Кошмо Штаттары
Sector-
Websitejaspertx.com
Analyst Ratings
Based on 6 analysts giving stock ratings to JSPR in the past 3 months
Buy
Buy
2
Hold
4
Sell
0
12 month forecast
Based on 6 Wall Street analysts offering 12 month price targets for JSPR in the last 3 months.
Highest
Current 0,46 USD
20,00 USD (+4 247,83%)
Average
7,88 USD (+1 613,04%)
Lowest
1,50 USD (+226,09%)
Analyst
Recommendation
Action
Price Target
Projected
Date
Matt Phipps
William Blair
Hold
Maintained
-
-
06/01/2026
Leonid Timashev
RBC Capital
Hold
Maintained
3,00 USD
+552,2%
05/14/2026
Yaron Werber
TD Cowen
Hold
Downgraded
-
-
05/15/2026
David Dai
UBS
Hold
Maintained
1,50 USD
+226,1%
04/02/2026
Gavin Clark-Gartner
Evercore ISI
Buy
Maintained
7,00 USD
+1 421,7%
04/01/2026
Emily Bodnar
H.C. Wainwright
Buy
Reiterated
20,00 USD
+4 247,8%
03/30/2026
Michael King
Rodman & Renshaw
Buy
Initiated
17,00 USD
+3 595,7%
01/13/2026
Previous reportsAll values in USD
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in USD
2025-ж. июн.
2025-ж. сен.
2025-ж. дек.
2026-ж. мар.
Revenue
-
-
-
-
Cost of goods sold
-
-
-
-
Cost of revenue
-
-
-
-
Research and development expenses
21,20 млн
13,10 млн
10,85 млн
5,81 млн
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
5,88 млн
4,26 млн
4,49 млн
5,14 млн
Operating expense
27,08 млн
17,36 млн
15,35 млн
10,95 млн
Total operating expenses
27,08 млн
17,36 млн
15,35 млн
10,95 млн
Operating income
-27,08 млн
-17,36 млн
-15,35 млн
-10,95 млн
Other non operating income
-84,00 миң
88,00 миң
6,40 млн
9,61 млн
EBT including unusual items
-26,72 млн
-18,74 млн
-9,10 млн
-1,17 млн
EBT excluding unusual items
-26,72 млн
-16,93 млн
-8,61 млн
-1,17 млн
Income tax expense
-
-
-
-
Effective tax rate
-
-
-
-
Other operating expenses
-
-
-
-
Net income
-26,72 млн
-18,74 млн
-9,10 млн
-1,17 млн
Net profit margin
-
-
-
-
Earnings per share
-1,74
-1,25
-0,54
-0,38
Interest and investment income
437,00 миң
342,00 миң
338,00 миң
164,00 миң
Interest expense
-
-
-
-
Net interest expenses
437,00 миң
342,00 миң
338,00 миң
164,00 миң
Depreciation and amortization charges
-
-
-
-
EBITDA
-26,82 млн
-17,13 млн
-15,06 млн
-10,93 млн
Gain or loss from assets sale
2,00 миң
-2,00 миң
-
-
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer

Research

AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer